Half of COVID-19 patients in NYC hospitals were admitted for something else — a sign of milder Omicron cases in vaccinated people
New Yorkreported more than 11,500 COVID-19hospitalizations on Friday — close to a record high.
- More than 40% of those patients, and half of hospitalized COVID-19 patients in
New York City, were admitted for an unrelated issue.
New York is approaching a record high number of COVID-19 hospitalizations nearly two years into the pandemic.
The state's COVID-19 hospitalizations rose 36% in a single week, from fewer than 8,500 hospitalized patients on New Year's Eve to more than 11,500 hospitalized patients on Friday, according to state data. (In comparison, New York recorded upward of 14,000 COVID-19 hospitalizations at once in April 2020.)
In New York City alone, more than 6,000 hospitalized patients had COVID-19 as of Friday — a 40% increase from the week prior.
But disease experts caution that these latest figures include people who were admitted to the hospital for ailments unrelated to COVID-19, then later diagnosed with the disease. Thus far, the
The chart below shows the breakdown of people hospitalized for COVID-19 as of Friday, versus patients who tested positive in the hospital, but were admitted for a different reason. Roughly half of COVID-19 patients in New York City hospitals, and 43% of hospitalized COVID-19 patients across the state, were admitted for an issue unrelated to the virus.
COVID-related admissions made up a much larger share of COVID-19 hospitalizations in central (80%) and western (73%) New York. These regions have lower vaccination rates than New York City and the state overall. Just 66% of people in central New York and 65% of people in western New York have had two vaccine doses, compared with 73% in New York City and 70% across the state.
COVID-19 can worsen outcomes for hospitalized patients with other illnesses
As Omicron cases continue to surge, vaccines have been instrumental at keeping hospitalizations at bay. A recent report from the UK Health Security Agency found that two vaccine doses lower the risk of an Omicron hospitalization by 65%, while three doses lower the risk by 81%.
Omicron may also cause milder disease on its own, though scientists are still trying to determine if that's the case. Two recent lab studies, which haven't been peer reviewed, suggest that Omicron may be less effective at attacking lung cells compared with other variants.
But an Omicron infection could exacerbate preexisting health conditions like cancer, diabetes, or kidney disease — especially for people hospitalized with these illnesses. People with diabetes who contract a viral infection, for instance, face an increased risk of diabetic ketoacidosis, a serious complication that can lead to coma or death.
Rising COVID-19 cases strain hospital capacity and threaten standards of care
An influx of COVID-19 patients may also hamper doctors' ability to provide adequate care, regardless of why patients were admitted to the hospital.
Many US hospitals are short-staffed due to a combination of burnout and hospital employees getting sick themselves. Nearly one-quarter of US hospitals now report a critical staffing shortage, according to data from the US Department of Health and Human Services.
"Admissions with COVID is still very disruptive to the healthcare system at a time when it can't afford more disruption," Dr. Ashish Jha, dean of the Brown University School of Public Health, wrote last week on Twitter.
COVID-19 patients have to be isolated, and doctors must don additional protective gear like gloves and face shields while treating them, Jha said. Those extra precautions "[slow] everyone down from seeing other patients," he added, and make surgery "much more complicated."
- This could be the best time to buy Galaxy Z Fold3 5G in India at ₹1,09,999
- Retail jobs have been slowing down due to WFH and online sales: report
- 85% Indian schools don't have vocational courses as part of their curriculum: WEF
- Govt invites bids for IDBI Bank privatisation; Govt, LIC to sell 60.72%
- Tracxn Technologies IPO: Analyst cautious due to losses and investor exits